Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and tolerability of 20% aluminum sesquichlorohydrate versus 20% aluminum chloride for the treatment of axillary hyperhidrosis
TCTR20200814009Phase 3Completed
- Sponsor
- Faculty of Medicine, Srinakharinwirot University
- Start
- Dec 2019
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aluminum sesquichlorohydrate, aluminum chloride in axillary hyperhidrosis, sponsored by Faculty of Medicine, Srinakharinwirot University. Started Dec 2019; status: completed.
02
Drugs
aluminum sesquichlorohydratealuminum chloride
03
Conditions
axillary hyperhidrosis
Beyond the preview
Go deeper on TCTR20200814009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200814009.